Cocrystal Pharma, Inc. Common Stock
Symbol: COCP (NASDAQ)
1.04
▲ (0.49%) 0.005
Company Description:
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Key Stats
- Today's Open: $1.02
- Today's High: $1.064
- Today's Low: $1.015
- Today's Volume: 146.09K
- Yesterday Close: $1.03
- Yesterday High: $1.0692
- Yesterday Low: $1.015
- Yesterday Volume: 231.74K
- Last Min Volume: 144
- Last Min High: $1.035
- Last Min Low: $1.035
- Last Min VWAP: $1.035
Company Profile
- Name: Cocrystal Pharma, Inc. Common Stock
- Website: https://www.cocrystalpharma.com
- Listed Date: 2008-04-01
- Location: BOTHELL, WA
- Market Status: Active
- CIK Number: 0001412486
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.82M
- Round Lot: 100
- Outstanding Shares: 13.04M
- Asset Type: CS
RECENT FILINGS FOR COCP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | SCHEDULE 13D/A | View |
| 2025-09-29 | 424B3 | View |
| 2025-09-25 | EFFECT | View |
| 2025-09-19 | S-1 | View |
| 2025-09-15 | 8-K | View |
| 2025-09-15 | 424B5 | View |
| 2025-09-12 | 8-K | View |
| 2025-09-12 | 8-K | View |
| 2025-09-12 | 424B3 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-05 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-05-29 | 8-K | View |
| 2025-05-15 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-05 | DEFA14A | View |
Latest News on COCP